Targeting the CD163+CD16+monocyte subset for the prevention and treatment of HIV-associated neurocognitive disorders (HAND)

被引：0
|
作者：
Gerngross, Lindsey [1 ]
Hardardt, Joseph [2 ]
Tedaldi, Ellen M. [3 ]
Fischer-Smith, Tracy [1 ]
机构：
[1] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA
[2] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA
[3] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19122 USA
来源：
JOURNAL OF NEUROVIROLOGY | 2013年 / 19卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P68
引用
收藏
页码：S32 / S33
页数：2
相关论文
共 50 条
  • [1] CD16+expressing monocyte subsets and CD14+HIV DNA levels predict HIV-associated neurocognitive disorders (HAND) in treatment-naive HIV infected Thai subjects
    Byron, Mary Margaret
    Valcour, Victor
    Ananworanich, Jintanat
    Agsalda, Melissa
    Chalermchai, Thep
    Tipsuk, Somporn
    Sithinamsuwan, Pasiri
    Schuetz, Alexandra
    Hutchings, Nicholas
    Barbour, Jason
    Phanuphak, Nittaya
    Shikuma, Cecilia
    Shiramizu, Bruce
    Ndhlovu, Lishomwa
    [J]. JOURNAL OF IMMUNOLOGY, 2013, 190
  • [2] HIV-Associated Neurocognitive Disorders (HAND)
    Elbirt, Daniel
    Mahlab-Guri, Keren
    Bezalel-Rosenberg, Shira
    Gill, Harpreet
    Attali, Malka
    Asher, Ilan
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2015, 17 (01): : 54 - 59
  • [3] Targeting the Glutamatergic System for the Treatment of HIV-Associated Neurocognitive Disorders
    Potter, Michelle C.
    Figuera-Losada, Mariana
    Rojas, Camilo
    Slusher, Barbara S.
    [J]. JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2013, 8 (03) : 594 - 607
  • [4] Targeting the Glutamatergic System for the Treatment of HIV-Associated Neurocognitive Disorders
    Michelle C. Potter
    Mariana Figuera-Losada
    Camilo Rojas
    Barbara S. Slusher
    [J]. Journal of Neuroimmune Pharmacology, 2013, 8 : 594 - 607
  • [5] Neuroimaging of HIV-associated neurocognitive disorders (HAND)
    Ances, Beau M.
    Hammoud, Dima A.
    [J]. CURRENT OPINION IN HIV AND AIDS, 2014, 9 (06) : 545 - 551
  • [6] CCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders
    Williams, Dionna W.
    Byrd, Desiree
    Rubin, Leah H.
    Anastos, Kathryn
    Morgello, Susan
    Berman, Joan W.
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2014, 1 (03):
  • [7] Rilpivirine as a potential candidate for the treatment of HIV-associated neurocognitive disorders (HAND)
    Ntshangase, Sphamandla
    Mdanda, Sipho
    Naicker, Tricia
    Kruger, Hendrik G.
    Govender, Thavendran
    Baijnath, Sooraj
    [J]. JOURNAL OF MOLECULAR HISTOLOGY, 2019, 50 (04) : 295 - 303
  • [8] Rilpivirine as a potential candidate for the treatment of HIV-associated neurocognitive disorders (HAND)
    Sphamandla Ntshangase
    Sipho Mdanda
    Tricia Naicker
    Hendrik G. Kruger
    Thavendran Govender
    Sooraj Baijnath
    [J]. Journal of Molecular Histology, 2019, 50 : 295 - 303
  • [9] Exploiting Unique Monocyte Phenotypes for Treatment Strategies for HIV-associated Neurocognitive Disorders
    Shiramizu, B.
    [J]. JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2012, 7 : S25 - S25
  • [10] Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND)
    Kolson, Dennis L.
    [J]. CURRENT HIV/AIDS REPORTS, 2022, 19 (05) : 344 - 357
12345